Clinical Trial Update: Long-Term Outcomes of Selexipag in Schistosomiasis-Associated Pulmonary Arterial Hypertension

View source ↗

Summary

Clinical trial update on the long-term outcomes of selexipag for schistosomiasis-associated pulmonary arterial hypertension; the study status is not yet recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension
• Schistosomiasis-associated Pulmonary Arterial Hypertension

Drugs mentioned

• Selexipag (selexipag)

Snippet

Sponsor: Caio Júlio César dos Santos Fernandes | Conditions: Pulmonary Arterial Hypertension (PAH) | Status: NOT_YET_RECRUITING